Major protease inhibitor drug resistance mutations among patients with virological failure on second-line antiretroviral therapy in Zimbabwe: a retrospective cross-sectional study.
- DOI
- 10.1186/s12985-026-03255-6
- Published
- 2026-07-10
- Container
- Virol J
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12985-026-03255-6,
title = {Major protease inhibitor drug resistance mutations among patients with virological failure on second-line antiretroviral therapy in Zimbabwe: a retrospective cross-sectional study.},
author = {Mayini J and Washaya T and Manasa J and Zumbika E and Munyati S and Shoko R and Dahlke C and Kouamou V.},
year = {2026},
journal = {Virol J},
doi = {10.1186/s12985-026-03255-6},
url = {https://doi.org/10.1186/s12985-026-03255-6}
}RIS
TY - JOUR TI - Major protease inhibitor drug resistance mutations among patients with virological failure on second-line antiretroviral therapy in Zimbabwe: a retrospective cross-sectional study. AU - Mayini J AU - Washaya T AU - Manasa J AU - Zumbika E AU - Munyati S AU - Shoko R AU - Dahlke C AU - Kouamou V. PY - 2026 JO - Virol J DO - 10.1186/s12985-026-03255-6 UR - https://doi.org/10.1186/s12985-026-03255-6 ER -
APA
J, M., T, W., J, M., E, Z., S, M., R, S., C, D., & V., K. (2026). Major protease inhibitor drug resistance mutations among patients with virological failure on second-line antiretroviral therapy in Zimbabwe: a retrospective cross-sectional study.. Virol J. https://doi.org/10.1186/s12985-026-03255-6
Source records
- europe-pmc · retrieved 2026-09-25T20:06:19.262Z